Leaders at All Levels: How Argenx Scaled to $4 Billion Without Bureaucracy
Episode details
Episode description
Businesses across industries share a common risk — the bigger they get, the less they innovate — and biotech companies are no exception. But Argenx, a European biotech with more than $40 billion in market value, seems to have cracked the code on how to avoid that pitfall. Incoming CEO Karen Massey explains how small teams and a relentless focus on patients have kept the company nimble and innovative. Timestamps: 0:00 – Introduction 0:52 – The Innovation Paradox 2:53 – The Argenx Model 10:46 – Scaling Without Hierarchy 15:20 – Cross-Functional Teams in Action 19:13 – Karen Massey’s Leadership Journey 21:02 – Actionable Advice for Leaders 22:57 – Host Reflections and Takeaways
Watch also from the same channel
More episodes from this channel
You might be interested in
